Valuing Innovation: Damages and Remedies in Life Sciences Arbitration

In this fast paced session, experts from FTI Consulting, Sofinnova Partners, and Bird & Bird will unpack one of the most complex issues in life sciences disputes: how to value innovation in arbitration, particularly in cases involving failed collaborations, terminated licences, milestone disputes and lost royalties.

We will dive into real world challenges around regulatory risk, how tribunals assess scientific uncertainty, future upside, and how drafting strategies can mitigate valuation disputes upfront. 
If you work in cross border life sciences collaborations, licensing, or contentious matters, this is one not to miss.

Click the 'Register' button to sign up and learn more.